3D-PRINTED CUSTOM INSOLES: ADVANCING DIABETIC FOOT CARE AT SENGKANG GENERAL HOSPITAL
SINGAPORE, July 8, 2025 /PRNewswire/ -- Sengkang General Hospital (SKH) has piloted an innovative approach to diabetic foot care through in-house production of 3D-printed custom insoles in a cross-institution collaboration with Singapore General Hospital's (SGH) 3D printing centre. Traditional pressure-relieving insoles, produced overseas, typically take up to two months to reach...
Zuellig Pharma Launches “Obesity is a Disease” Seminar as Part of “Reduce Size, Reduce Disease” Campaign
The campaign aims to enhance the understanding of obesity as a chronic disease and solutions to help manage the disease among Thais and healthcare providers. BANGKOK, July 8, 2025 /PRNewswire/ -- Zuellig Pharma, a leading healthcare solutions provider in Asia, is organizing the "Obesity is a Disease" seminar as part of its "Reduce Size, Reduce Disease" awareness campaign. The seminar aims...
WuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition Activities
SHANGHAI, July 8, 2025 /PRNewswire/ -- WuXi AppTec Co., Ltd. (Stock codes: 603259.SH/2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, recently provided updates to investors on the status of its A-share repurchase and H-share acquisition activities in Q2 2025. The Company repurchased and...
Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo)
STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of PROLIA® (denosumab) and XGEVA® (denosumab) respectively, STOBOCLO and OSENVELT, among the first wave of biosimilars referencing PROLIA and XGEVA respectively, are commercially available in the U.S. Celltrion further expands its portfolio, delivering cost-effective and high-quality biologic medicines to...
SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V
SINGAPORE, July 8, 2025 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced today that the China National Medical Products Administration (NMPA) has cleared the Investigational New Drug (IND) application for SCG101V, marking the first-ever investigational cell therapy to enter regulatory approved Phase 1/2...
Better by MTA Highlights Platinum Members Elevating Global Healthcare Standards
PALM BEACH GARDENS, Fla., July 8, 2025 /PRNewswire/ -- Better by MTA, the leading medical tourism platform, is proud to spotlight its distinguished Platinum Members—organizations that exemplify leadership, excellence, and innovation in the global medical travel industry. These members have played a key role in driving forward Better by MTA's mission to enhance transparency, access, and quality across borders....
Sirtex Medical’s SIR-Spheres® Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma
Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma and metastatic colorectal cancer WOBURN, Mass., July 7, 2025 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of interventional oncology solutions, today announced that the U.S. Food...
WuXi AppTec Receives MSCI ESG AAA Leader Rating
SHANGHAI, July 7, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, today announced it has achieved the AAA rating – the highest level – from MSCI in its latest annual Environmental, Social, and Governance (ESG) ratings. This is the first...
Coreline Soft and Temple Health to Co-Host Webinar on AI-Driven Lung Cancer Screening and Improving Patient Outcomes
Real-world outcomes: How AI improved both diagnostic efficiency, early detection, and comorbidity detection Deep dive into the precision technology of the FDA-cleared platform, AVIEW LCS Plus PHILADELPHIA and SEOUL, South Korea, July 7, 2025 /PRNewswire/ -- Coreline Soft, a leading provider of AI-based medical imaging solutions, announced it will co-host a...
The Voices of Persons Affected by Hansen’s Disease Move the World: 3rd Global Forum Held in Bali, Indonesia
TOKYO, July 7, 2025 /PRNewswire/ -- In a landmark gathering that placed lived experience at the center of global health discourse, the 3rd Global Forum of People's Organizations on Hansen's Disease was held in Bali, Indonesia, from July 4 to 6, 2025. Organized by the Sasakawa Leprosy (Hansen's Disease) Initiative, the event brought together over 110 representatives of organizations of...
